U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 1 Creatinine Increased, CTCAE

MedGen UID:
1632570
•Concept ID:
C4685087
•
Finding

Definition

>ULN-1.5 x ULN [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 1 Creatinine Increased, CTCAE

Professional guidelines

PubMed

Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients.
Zazuli Z, Otten LS, Drögemöller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, McGoldrick N, Kitchlu A, Vijverberg SJH, Masereeuw R, Ross CJD, Liu G, Carleton BC, Maitland-van der Zee AH
Genes (Basel) 2019 May 10;10(5) doi: 10.3390/genes10050364. PMID: 31083486Free PMC Article

Recent clinical studies

Etiology

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, Kaki T, Harutani Y, Furuta K, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Ozawa Y, Nakanishi M, Koh Y, Shimokawa T, Yamamoto N
Cancer Med 2024 Feb;13(4):e6839. doi: 10.1002/cam4.6839. PMID: 38457231Free PMC Article
Long-term Nephrotoxicity after PRRT: Myth or Reality.
Baum RP, Fan X, Jakobsson V, Yu F, Schuchardt C, Chen X, Zhang J
Theranostics 2024;14(2):451-459. Epub 2024 Jan 1 doi: 10.7150/thno.92487. PMID: 38169589Free PMC Article
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.
Nihei S, Ikeda T, Aoki T, Murasato F, Yaegashi M, Asahi K, Kudo K
Cancer Chemother Pharmacol 2023 May;91(5):427-434. Epub 2023 Apr 10 doi: 10.1007/s00280-023-04532-9. PMID: 37036487
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ
Eur J Nucl Med Mol Imaging 2016 Sep;43(10):1802-11. Epub 2016 May 10 doi: 10.1007/s00259-016-3382-9. PMID: 27160225Free PMC Article
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate.
Sabet A, Ezziddin K, Pape UF, Reichman K, Haslerud T, Ahmadzadehfar H, Biersack HJ, Nagarajah J, Ezziddin S
Eur J Nucl Med Mol Imaging 2014 Mar;41(3):505-10. Epub 2013 Nov 6 doi: 10.1007/s00259-013-2601-x. PMID: 24196919

Diagnosis

Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.
Nihei S, Ikeda T, Aoki T, Murasato F, Yaegashi M, Asahi K, Kudo K
Cancer Chemother Pharmacol 2023 May;91(5):427-434. Epub 2023 Apr 10 doi: 10.1007/s00280-023-04532-9. PMID: 37036487
Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
Fathpour G, Jafari E, Hashemi A, Dadgar H, Shahriari M, Zareifar S, Jenabzade AR, Vali R, Ahmadzadehfar H, Assadi M
Clin Nucl Med 2021 Jul 1;46(7):540-548. doi: 10.1097/RLU.0000000000003577. PMID: 33782280

Therapy

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, Kaki T, Harutani Y, Furuta K, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Ozawa Y, Nakanishi M, Koh Y, Shimokawa T, Yamamoto N
Cancer Med 2024 Feb;13(4):e6839. doi: 10.1002/cam4.6839. PMID: 38457231Free PMC Article
Long-term Nephrotoxicity after PRRT: Myth or Reality.
Baum RP, Fan X, Jakobsson V, Yu F, Schuchardt C, Chen X, Zhang J
Theranostics 2024;14(2):451-459. Epub 2024 Jan 1 doi: 10.7150/thno.92487. PMID: 38169589Free PMC Article
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.
Nihei S, Ikeda T, Aoki T, Murasato F, Yaegashi M, Asahi K, Kudo K
Cancer Chemother Pharmacol 2023 May;91(5):427-434. Epub 2023 Apr 10 doi: 10.1007/s00280-023-04532-9. PMID: 37036487
Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
Fathpour G, Jafari E, Hashemi A, Dadgar H, Shahriari M, Zareifar S, Jenabzade AR, Vali R, Ahmadzadehfar H, Assadi M
Clin Nucl Med 2021 Jul 1;46(7):540-548. doi: 10.1097/RLU.0000000000003577. PMID: 33782280
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ
Eur J Nucl Med Mol Imaging 2016 Sep;43(10):1802-11. Epub 2016 May 10 doi: 10.1007/s00259-016-3382-9. PMID: 27160225Free PMC Article

Prognosis

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, Kaki T, Harutani Y, Furuta K, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Ozawa Y, Nakanishi M, Koh Y, Shimokawa T, Yamamoto N
Cancer Med 2024 Feb;13(4):e6839. doi: 10.1002/cam4.6839. PMID: 38457231Free PMC Article
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.
Nihei S, Ikeda T, Aoki T, Murasato F, Yaegashi M, Asahi K, Kudo K
Cancer Chemother Pharmacol 2023 May;91(5):427-434. Epub 2023 Apr 10 doi: 10.1007/s00280-023-04532-9. PMID: 37036487
The impact of repeated cycles of radioligand therapy using [(177)Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.
Yordanova A, Becker A, Eppard E, Kürpig S, Fisang C, Feldmann G, Essler M, Ahmadzadehfar H
Eur J Nucl Med Mol Imaging 2017 Aug;44(9):1473-1479. Epub 2017 Mar 23 doi: 10.1007/s00259-017-3681-9. PMID: 28337529
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ
Eur J Nucl Med Mol Imaging 2016 Sep;43(10):1802-11. Epub 2016 May 10 doi: 10.1007/s00259-016-3382-9. PMID: 27160225Free PMC Article

Clinical prediction guides

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, Kaki T, Harutani Y, Furuta K, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Ozawa Y, Nakanishi M, Koh Y, Shimokawa T, Yamamoto N
Cancer Med 2024 Feb;13(4):e6839. doi: 10.1002/cam4.6839. PMID: 38457231Free PMC Article
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer.
Nihei S, Ikeda T, Aoki T, Murasato F, Yaegashi M, Asahi K, Kudo K
Cancer Chemother Pharmacol 2023 May;91(5):427-434. Epub 2023 Apr 10 doi: 10.1007/s00280-023-04532-9. PMID: 37036487
Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma.
Fathpour G, Jafari E, Hashemi A, Dadgar H, Shahriari M, Zareifar S, Jenabzade AR, Vali R, Ahmadzadehfar H, Assadi M
Clin Nucl Med 2021 Jul 1;46(7):540-548. doi: 10.1097/RLU.0000000000003577. PMID: 33782280
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ
Eur J Nucl Med Mol Imaging 2016 Sep;43(10):1802-11. Epub 2016 May 10 doi: 10.1007/s00259-016-3382-9. PMID: 27160225Free PMC Article
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate.
Sabet A, Ezziddin K, Pape UF, Reichman K, Haslerud T, Ahmadzadehfar H, Biersack HJ, Nagarajah J, Ezziddin S
Eur J Nucl Med Mol Imaging 2014 Mar;41(3):505-10. Epub 2013 Nov 6 doi: 10.1007/s00259-013-2601-x. PMID: 24196919

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...